CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Adragos Pharma Completes Expansion with New Ampoule Fill and Finish Line in Livron 

Adragos Pharma, a leading Contract Development & Manufacturing Organisation (CDMO), has significantly enhanced its production capabilities with the completion of...
Continue Reading →
News

PCI Pharma Services and ChiRhoClin Partner to Prevent Shortage of Critical Orphan Pancreatic Drug

Leading CDMO performing sterile drug manufacturing, lyophilisation testing/QA and packaging operations for mission-critical drug. Philadelphia, PA – PCI Pharma Se...
Continue Reading →
Volume 15 Issue 3

Integrated CDMO Partner for Parenteral Drug Products

IPI Speaks with Mr Anil Busimi, VP, Strategy & Marketing of Terumo Medical Care Solutions (TMCS)on the Recent Changes in the CDMO Industry and what the Market is...
Continue Reading →
Volume 13 Issue 4

How to Coordinate Your Site Selection With State Economic Development

Where are your labs located? Development/pilot/clinical material facilities? Commercial plants? If these do not exist, where should you build them? If outsourcing, w...
Continue Reading →
Volume 13 Issue 4

The Importance of Clinical Trial Packaging and The Benefits in Outsourcing Your Small Molecule Packaging to a CDMO

Operating a clinical trial in what is a tightly regulated industry requires comprehensive, big picture thinking. Risks remain at all stages of the clinical supply ch...
Continue Reading →
News

Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services

Company plans wide-ranging investments and expansions to keep pace with demand driven by macro-changes and diversifying client base Aragen Life Sciences (for...
Continue Reading →
News

WuXi STA first CDMO to support the approval of an innovative drug in China through the “MAH” pilot

WuXi STA enables Ascletis to receive NDA Approval from China FDA for Ganovo® STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, announces that its...
Continue Reading →
News

Ardena acquires Syntagon and strengthens API offering

Contract development and manufacturing organisation (CDMO) Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (...
Continue Reading →
News

Saneca Pharma strengthens team with new sales director

Slovakia-based contract development and manufacturing organization (CDMO) Saneca Pharma has strengthened its team with the appointment of a new CDMO sales director a...
Continue Reading →
News

Recipharm equips a further three facilities for US serialisation

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its facilities with serialisation capabilities in line wit...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026